Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolitesMarguerite A. Butler, Fred F. Kadlubar, P Vineis et al.|Pharmacogenetics|1992Cited by 418
Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colonRobert J. Turesky, Fred F. Kadlubar, Candee H. Teitel et al.|Carcinogenesis|1991Cited by 342
N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cellsRodney F. Minchin, Fred F. Kadlubar, B. Mojarrabi et al.|Biochemical and Biophysical Research Communications|1992Cited by 248
Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expressionBrian Coles, Fred F. Kadlubar, Claudine Rauch et al.|Pharmacogenetics|2001Cited by 224